Sanofi Blocks COVID-19 Vaccine Trademark In EU
Sanofi's vaccine subsidiary has convinced officials at the European Union's Intellectual Property Office to block an Indian biopharma company's bid to trademark for 'Covaxin Bharat Biotech,' after arguing that consumers would...To view the full article, register now.
Already a subscriber? Click here to view full article